GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Collegium Pharmaceutical Inc (FRA:354) » Definitions » Total Stockholders Equity

Collegium Pharmaceutical (FRA:354) Total Stockholders Equity : €216.9 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Collegium Pharmaceutical Total Stockholders Equity?

Collegium Pharmaceutical's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €216.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Collegium Pharmaceutical's Book Value per Share for the quarter that ended in Mar. 2025 was €6.75. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Collegium Pharmaceutical's Debt-to-Equity for the quarter that ended in Mar. 2025 was 3.60.


Collegium Pharmaceutical Total Stockholders Equity Historical Data

The historical data trend for Collegium Pharmaceutical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Collegium Pharmaceutical Total Stockholders Equity Chart

Collegium Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 152.92 179.59 183.93 179.21 218.54

Collegium Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 204.40 201.21 211.09 218.54 216.85

Collegium Pharmaceutical  (FRA:354) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Collegium Pharmaceutical's Book Value per Share for the quarter that ended in Mar. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Collegium Pharmaceutical's Debt-to-Equity for the quarter that ended in Mar. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Collegium Pharmaceutical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Collegium Pharmaceutical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Collegium Pharmaceutical Business Description

Traded in Other Exchanges
Address
100 Technology Center Drive, Stoughton, MA, USA, 02072
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical Headlines

No Headlines